Cancer cell fusion study showcased in Science

Cell fusion is one of the ways that tumors can gain abilities to become life-threatening and resist treatment, Melissa Wong, Ph.D., and colleagues first reported last year. The paper now is one of...

Targeting osteosarcoma, a cancer more common in young people

Knight Cancer researchers describe positive results with the drug regorafenib. Osteosarcoma is a bone cancer that disproportionately affects teenagers, and despite substantial efforts, outcomes for...

Should health plans cover fertility preservation for cancer patients?

Young adults undergoing toxic therapies for cancer have highly effective options to preserve fertility. But the great cost – easily $15,000 or more for a woman – puts the option out of the reach...

Eleven inspired projects underway with Knight Cancer pilot funds

Exploring immune therapy combinations to stop aggressive breast cancers. Unraveling the gene changes that make juvenile myelomonocytic leukemia so difficult-to-treat. Developing a biomarker to guide...

Long after childbirth, a persistent risk for metastatic breast cancer

Breast cancers that emerge after a woman gives birth are significantly more likely to spread and become life-threatening. And this elevated risk endures for at least 10 years, a new study has...

Studies reveal new ways to fight a deadly leukemia

One study shows how it may be possible to stop acute myeloid leukemia by targeting a hidden population of cells that support the cancer. Another reveals how AML evolves to evade anti-cancer drugs,...

Big milepost for a Knight Cancer scientist: 1000 papers

Gordon Mills, M.D., Ph.D., was fresh out of college when his first journal article appeared in 1976. He’s been quite busy since then, with a publication count that just hit quadruple...

Introducing Knight School

A new series of science talks produced by the OHSU Knight Cancer Institute debuts this month in Portland. Researchers, clinicians and patients are going on stage to present interconnected stories of...